Association between the Interleukin-6 Gene -572 C/G Polymorphism and the Risk of Type 2 Diabetes Mellitus: A Meta-Analysis of 11,681 Subjects

Annals of Human Genetics

Volumn 77, Issue 2, 2013, Pages 106-114

  Yin, Yan Wei ^a   Sun, Qian Qian ^b   Zhang, Bei Bei ^c   Hu, Ai Min ^a   Liu, Hong Li ^a   Wang, Qi ^a   Zeng, Yi Hua ^a   Xu, Rui Jia ^a   Zhang, Zhong Dong ^a   Zhang, Zhi Guo ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b Jinsong Sanatorium of Beijing Air Force   (China)

^c General Hospital of PLA Chengdu Military Area Command   (China)

Author keywords

Interleukin 6; Meta analysis; Polymorphism; Type 2 diabetes mellitus

Indexed keywords

INTERLEUKIN 6;

ALLELE; ARTICLE; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PUBLISHING; SENSITIVITY ANALYSIS;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84874018827     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/ahg.12003     Document Type: Article

References (36)

1. Almgren, P., Lehtovirta, M., Isomaa, B., Sarelin, L., Taskinen, M. R., Lyssenko, V., Tuomi, T., & Groop, L.; Botnia Study Group. (2011) Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 54, 2811-2819.
2. An, X. H., Song, D. P., Liu, H., Wang, Y. M. & Duan, Y. (2007) The association of IL-6 gene promoter region -643 C/G polymorphism with diabetic nephropathy. Chin J Diabetes 15, 289-291.
3. Berkey, C. S., Hoaglin, D. C., Mosteller, F. & Colditz, G. A. (1995) A random-effects regression model for meta-analysis. Stat Med 14, 395-411.
4. Borges, A. P., Guidoni, C. M., de Freitas, O. & Pereira, L. R. (2011) Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arq Bras Endocrinol Metabol 55, 686-691.
5. Brull, D. J., Montgomery, H. E., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., Lowe, G. D. & Humphries, S. E. (2001) Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21, 1458-1463.
6. Chen, J. N., Yin, Y. S. & Li, X. L. (2009) The genotype of IL-6 gene in patients with type 2 diabetic nephropathy. Acta Med Sin 22, 801-804.
7. Deng, Y. P., Xu, Y. C. & Zhang, Y. (2004) Association of IL-6 gene polymorphism with diabetic nephropathy in type 2 diabetes. J N Med 14, 21-23.
8. DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Control Clin Trials 7, 177-188.
9. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634.
10. Fernández-Real, J. M. & Ricart, W. (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24, 278-301.
11. Festa, A., D'Agostino, R. Jr., Howard, G., Mykkänen, L., Tracy, R. P. & Haffner SM. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS). Circulation 102, 42-47.
12. Fried, S. K., Bunkin, D. A. & Greenberg, A. S. (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847-850.
13. Gulliford, M. C. & Charlton, J. (2009) Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol 169, 455-461.
14. Hamid, Y. H., Rose, C. S., Urhammer, S. A., Glümer, C., Nolsøe, R., Kristiansen, O. P., Mandrup-Poulsen, T., Borch-Johnsen, K., Jorgensen, T., Hansen, T. & Pedersen O. (2005) Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48, 251-260.
15. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. (1995) Measuring inconsistency in meta-analyses. BMJ 327, 557-560.
16. Huth, C., Heid, I. M., Vollmert, C., Gieger, C., Grallert, H., Wolford, J. K., Langer, B., Thorand, B., Klopp, N., Hamid, Y. H., Pedersen, O., Hansen, T., Lyssenko, V., Groop, L., Meisinger, C., Döring, A., Löwel, H., Lieb, W., Hengstenberg, C., Rathmann, W., Martin, S., Stephens, J. W., Ireland, H., Mather, H., Miller, G. J., Stringham, H. M., Boehnke, M., Tuomilehto, J., Boeing, H., Möhlig, M., Spranger, J., Pfeiffer, A., Wernstedt, I., Niklason, A., López-Bermejo, A., Fernández-Real, J. M., Hanson, R. L., Gallart, L., Vendrell, J., Tsiavou, A., Hatziagelaki, E., Humphries, S. E., Wichmann, H. E., Herder, C., Illig, T. (2006) IL6 gene promoter polymorphisms and type 2 diabetes: Joint analysis of individual participants' data from 21 studies. Diabetes 55, 2915-2921.
17. International Diabetes Federation. (2012) Available at: http://www.diabetesatlas.org/content/diabetes. Accessed Feb. 10, 2012.
18. International HapMap Project. (2012) Available at: http://hapmap.ncbi.nlm.nih.gov. Accessed June 25, 2012.
19. Kitamura, A., Hasegawa, G., Obayashi, H., Kamiuchi, K., Ishii, M., Yano, M., Tanaka, T., Yamaguchi, M., Shigeta, H., Ogata, M., Nakamura, N. & Yoshikawa, T. (2002) Interleukin-6 polymorphism (-634C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 19, 1000-1005.
20. Koh, S. J., Jang, Y., Hyun, Y. J., Park, J. Y., Song, Y. D., Shin, K. K., Chae, J. S., Kim, B. K., Ordovas, J. M. & Lee, J. H. (2009) Interleukin-6 (IL-6) -572C->G promoter polymorphism is associated with type 2 diabetes risk in Koreans. Clin Endocrinol (Oxf) 70, 238-244.
21. Mantel, N. & Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748.
22. Mathias, R. A., Deepa, M., Deepa, R., Wilson, A. F. & Mohan, V. (2009) Heritability of quantitative traits associated with type 2 diabetes mellitus in large multiplex families from South India. Metabolism 58, 1439-1445.
23. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S. & Coppack, S. W. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82, 4196-4200.
24. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G.; PRISMA Group. (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151, 264-269.
25. Newman, B., Selby, J. V., King, M. C., Slemenda, C., Fabsitz, R., Friedman, G. D. (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30, 763-768.
26. Pickup, J. C., Mattock, M. B., Chusney, G. D. & Burt, D. (1997) NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40, 1286-1292.
27. Pradhan, A. D., Manson, J. E., Rifai, N., Buring J. E. & Ridker, P. M. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334.
28. Qi, L., van, Dam, R. M., Meigs, J. B., Manson, J. E., Hunter, D. & Hu, F. B. (2006) Genetic variation in IL6 gene and type 2 diabetes: Tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 15, 1914-1920.
29. Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H. & Pfeiffer, A. F. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52, 812-817.
30. Stumvoll, M., Goldstein, B. J. & van Haeften, T. W. (2005) Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 365, 1333-1346.
31. Tang, S. F., Wei, H. Y. & Zhang, P. (2010) The polymorphism of the interleukin-6 promoter in patients with type 2 diabetes mellitus complicated with low-extremity vascular disease. Chin J Prev Contr Chron Dis 18, 156-160.
32. Wang, Y. X., Kong, L. F. & Wang X. Y. (2010) The association of IL-6 gene 572C/G polymorphism and type 2 diabetes. J China Med Univ 39, 1045-1054.
33. Wells, G. A., Shea, B. & O'Connell, D. (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed Oct. 20, 2011.
34. Xiao, L. M., Yan, Y. X., Xie, C. J., Fan, W. H., Xuan, D. Y., Wang, C. X., Chen, L., Sun, S. Y., Xie, B. Y. & Zhang, J. C. (2009) Association among interleukin-6 gene polymorphism, diabetes and periodontitis in a Chinese population. Oral Dis 15, 547-553.
35. Zhang, X., Ma, L., Peng, F., Wu, Y., Chen, Y., Yu, L., Lei, Z. & Zhang, C. (2011) The endothelial dysfunction in patients with type 2 diabetes mellitus is associated with IL-6 gene promoter polymorphism in Chinese population. Endocrine 40, 124-129.
36. Zintzaras, E. & Lau, J. (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61, 634.